GLAND PHARMA
|
The Current P/E Ratio of GLAND PHARMA is 43.22.
Share Price | ₹1,813.8 | Dec 03,2024 |
Market Cap | ₹29,890.6 Cr | |
Earnings-TTM | ₹691.6 Cr | TTM-Consolidated Results |
Price/Earnings | 43.22x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of GLAND PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹29,890.6 Cr] as on Dec 03,2024
(/) Earnings [ ₹691.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 43.22x ]
Thus, for GLAND PHARMA , the investors are currently willing to pay 43.22 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GLAND PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of GLAND PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of GLAND PHARMA
PE Ratio Performance Analysis for GLAND PHARMA
- GLAND PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 30.20x.
- GLAND PHARMA 's operated at median p/e ratio of 39.27x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLAND PHARMA 's p/e ratio peaked in Mar2022 at 44.33x.
- GLAND PHARMA 's p/e ratio hit its five-year low in Mar2020 of 0x.
How does GLAND PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
GLAND PHARMA | 691.57 | 43.22 | 29,890.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.75 | 431,544.0 |
CIPLA LTD | 4,485.22 | 27.63 | 123,920.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 18.91 | 102,224.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.99 | 98,832.3 |
DIVIS LABORATORIES LTD | 1,836.00 | 89.80 | 164,865.0 |
MANKIND PHARMA LTD | 2,124.86 | 48.25 | 102,527.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 63.14 | 113,772.0 |
LUPIN LTD | 2,651.94 | 35.81 | 94,953.0 |
AUROBINDO PHARMA LTD | 3,598.83 | 20.44 | 73,544.0 |
ABBOTT INDIA LTD | 1,284.66 | 47.05 | 60,440.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs GLAND PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.91x |
Max industry PE | 89.80x |
Median industry PE | 38.75x |
Average industry PE | 41.45x |
You may also like the below Video Courses